| Market Cap | ₹113Cr |
| ROE | 35.97% |
| P/E Ratio(TTM) | 24.13 |
| EPS(TTM) | 3.73 |
| P/B Ratio | 2.22 |
| Dividend Yield | 0.00% |
| Industry P/E | 59.77 |
| Book Value | 40.53 |
| Debt to Equity | 0.26 |
| Face Value | 10 |
| Parent Organisation | Invicta Diagnostic |
| NSE Symbol | INVICTA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 44.82 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 67.51 | ||
| Metropolis Healthcare | NA (0.00%) | 62.76 | ||
| Thyrocare Technologies | NA (0.00%) | 54.62 |